CHRONIC HEPATITIS C

This study tested a new drug called MP-424 combined with two standard medications (peginterferon alfa-2b and ribavirin) in 108 adults with genotype 2 hepatitis C whose infection returned after previous treatment. The goal was to see if the combination could clear the virus comple…

This study tested a new drug called MP-424 combined with two standard medicines (peginterferon alfa-2b and ribavirin) in 109 people with genotype 1 hepatitis C whose infection returned after previous treatment. The goal was to see if the combination could clear the virus complete…

This study tested a drug called ursodeoxycholic acid (UDCA) in 596 adults with chronic hepatitis C. The goal was to see if higher doses (600 or 900 mg per day) could better lower liver enzyme levels than a low dose (150 mg per day) over 24 weeks. The trial was completed in Japan …

This study tested a new drug called MP-424 combined with two standard hepatitis C medicines (peginterferon alfa-2b and ribavirin) in 10 people with genotype 2 hepatitis C who had not responded to earlier treatment. The main goal was to see if the virus could be cleared from the b…

This study looked at whether adding vitamin D to the usual hepatitis C drugs (pegylated interferon and ribavirin) helps clear the virus in people who didn't respond to treatment before. 32 adults with chronic hepatitis C (genotype 1 or 4) and low vitamin D levels took part. The g…

This early-stage study tested a single dose of the experimental drug MP-424 in 10 people with chronic hepatitis C (genotype 1b). The main goals were to check the drug's safety and how it behaves in the body. Researchers also measured how the drug affected hepatitis C virus levels…